PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Alto Marketing Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

TTP LabTech Launches the New Mirrorball™ System - TTP LabTech has today unveiled Mirrorball™, its new high sensitivity laser scanning microplate cytometer for antibody discovery
TTP LabTech Launches the New Mirrorball™ System

 

NewswireToday - /newswire/ - Southampton, Hampshire, United Kingdom, 2010/04/14 - TTP LabTech has today unveiled Mirrorball™, its new high sensitivity laser scanning microplate cytometer for antibody discovery.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Today on the opening day of the exhibition at the SBS 16th Annual Conference & Exhibition, TTP LabTech announce the exciting launch of Mirrorball™, a new high sensitivity laser scanning microplate cytometer for antibody discovery. Developed by an in-house team of leading experts, Mirrorball is set to fill a critical role in the antibody discovery process by rapidly and reliably performing mix-and–read, cell- or bead-based assays. In essence, this instrument offers a simple and easy solution to automated hybridoma screening and will not require the reworking of existing protocols.

Dr Jas Sanghera, Commercial Director of TTP LabTech commented, “TTP LabTech has been pioneering laser scanning cytometry since the launch of ChemScan in 1994, Acumen Explorer in 2000, and the triple laser Acumen eX3 in 2006. The introduction of Mirrorball maintains our unique position in this market and will revolutionise the antibody discovery process.”

Mirrorball addresses one of the currently unmet needs of laser scanning instrumentation – that of high sensitivity – with its proprietary high performance, low-loss optics. Mirrorball (the-mirrorball.com) is also the first laser scanning microplate cytometer to offer simultaneous laser scanning. This will enable superior multiplexing resulting in higher throughput single pass scanning. This instrument is available in three upgradeable configurations; the highest specification will offer dual laser excitation (488 nm and 640 nm), four fluorescence data channels and a single laser scatter channel. Mirrorball’s laser scatter channel enables label-free object recognition independent of fluorescence, which can be combined with concurrent collection of fluorescence data for even greater sensitivity in multiplexed assays.

Dr Wayne Bowen, Chief Scientific Officer at TTP LabTech, explained the strategy behind the new development. “Mirrorball is TTP LabTech’s response to requests for novel technologies in antibody discovery. We’ve listened, developed and now delivered a high sensitivity microplate cytometer for fluorescence cellular screening.”

About TTP LabTech Limited

Based near Cambridge, UK, TTP LabTech Ltd (ttplabtech.com) supplies laboratory-scale instrumentation, develops custom automation and now provides contract screening services for life sciences companies spanning the healthcare, biotech and pharmaceutical sectors. TTP LabTech’s approach is to provide its customers with flexible solutions which can be tailored to meet their needs.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Alto Marketing Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


TTP LabTech Launches the New Mirrorball™ System

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Leigh Dilley - Alto-Marketing.com 
+44 1489 557672 catherines[.]alto-marketing.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Alto Marketing Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Alto Marketing Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  1Click Games





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)